The original success of Sildenafil undeniably reshaped the medication landscape, but investing in companies strongly reliant on off-patent versions presents a complex picture. Although early profits were significant, https://pharma446638.blogcudinti.com/41929022/sildenafil-and-pharma-a-risky-bet